• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.

作者信息

Yazaki Yoshiyuki, Nakamura Masato, Iijima Raisuke, Yasuda Satoshi, Kaikita Koichi, Akao Masaharu, Ako Junya, Matoba Tetsuya, Miyauchi Katsumi, Hagiwara Nobuhisa, Kimura Kazuo, Hirayama Atsushi, Matsui Kunihiko, Ogawa Hisao

机构信息

Division of Cardiovascular Medicine, Toho University, Ohashi Medical Center, Meguro-ku, Tokyo, Japan (Y.Y., M.N., R.I.).

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan (S.Y.).

出版信息

Circulation. 2021 Oct 26;144(17):1449-1451. doi: 10.1161/CIRCULATIONAHA.121.055374. Epub 2021 Oct 25.

DOI:10.1161/CIRCULATIONAHA.121.055374
PMID:34694893
Abstract
摘要

相似文献

1
Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.利伐沙班单药治疗合并心房颤动和稳定型冠心病的心力衰竭患者的临床结局：来自AFIRE试验的见解
Circulation. 2021 Oct 26;144(17):1449-1451. doi: 10.1161/CIRCULATIONAHA.121.055374. Epub 2021 Oct 25.
2
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.利伐沙班单药治疗与双联抗血小板治疗在伴有稳定型冠状动脉疾病的心房颤动患者中的全血栓栓塞和出血事件的比较：AFIRE 试验的事后二次分析。
JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561.
3
Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting: Insights From the AFIRE Trial.冠状动脉支架置入术后非瓣膜性心房颤动患者应用利伐沙班单药治疗：来自 AFIRE 试验的结果。
JACC Cardiovasc Interv. 2021 Nov 8;14(21):2330-2340. doi: 10.1016/j.jcin.2021.07.045.
4
Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study.稳定型冠状动脉疾病患者应用利伐沙班发生心房颤动和缺血性事件（AFIRE）：一项多中心、前瞻性、随机、开放标签、平行分组研究方案。
Int J Cardiol. 2018 Aug 15;265:108-112. doi: 10.1016/j.ijcard.2018.04.131. Epub 2018 May 2.
5
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.心房颤动合并稳定性冠心病的抗栓治疗。
N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2.
6
Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis.利伐沙班单药治疗多支血管或左主干冠状动脉支架置入的心房颤动患者：AFIRE试验亚组分析
J Am Heart Assoc. 2022 Nov;11(21):e027107. doi: 10.1161/JAHA.122.027107. Epub 2022 Oct 26.
7
Does atorvastatin therapy change the anti-Xa activity in xabans-treated patients with atrial fibrillation?阿托伐他汀治疗是否会改变华法林治疗的心房颤动患者的抗 Xa 活性？
Pharmacol Res Perspect. 2021 May;9(3):e00730. doi: 10.1002/prp2.730.
8
Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings.利伐沙班用于伴有稳定型冠状动脉疾病的心房颤动的剂量不足：AFIRE 试验结果。
Thromb Haemost. 2022 Sep;122(9):1584-1593. doi: 10.1055/s-0042-1744543. Epub 2022 Jun 13.
9
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial.心力衰竭和冠状动脉疾病恶化患者新发心房颤动：来自 COMMANDER-HF 试验的分析。
Clin Res Cardiol. 2022 Jan;111(1):50-59. doi: 10.1007/s00392-021-01891-2. Epub 2021 Jun 14.
10
Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis.利伐沙班单药治疗与联合治疗在房颤和稳定型冠心病患者的卒中与出血风险中的比较：AFIRE 试验亚组分析。
Am Heart J. 2021 Jun;236:59-68. doi: 10.1016/j.ahj.2021.02.021. Epub 2021 Feb 28.

引用本文的文献

1
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias.《日本循环学会/日本心律学会2024年心律失常管理指南重点更新》
J Arrhythm. 2025 Jun 16;41(3):e70033. doi: 10.1002/joa3.70033. eCollection 2025 Jun.
2
Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries.利伐沙班在临床实践中用于心房颤动合并心力衰竭患者的有效性和安全性：国内外注册研究的间接比较
Front Cardiovasc Med. 2025 May 27;12:1451499. doi: 10.3389/fcvm.2025.1451499. eCollection 2025.
3
BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention.
脑钠肽水平可预测经皮冠状动脉介入治疗后心力衰竭患者的出血事件。
Open Heart. 2023 Dec 7;10(2):e002489. doi: 10.1136/openhrt-2023-002489.